Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,908
Closed -$976K 1580
2026
Q1
$976K Buy
12,908
+3,291
+34% +$247K 0.03% 409
2025
Q4
$716K Buy
+9,617
New +$703K 0.02% 593
2025
Q1
Sell
-11,564
Closed -$834K 1383
2024
Q4
$834K Buy
11,564
+7,088
+158% +$554K 0.04% 411
2024
Q3
$365K Sell
4,476
-3,391
-43% -$271K ﹤0.01% 3129
2024
Q2
$584K Buy
+7,867
New +$590K ﹤0.01% 2564
2024
Q1
Sell
-11,721
Closed -$872K 4110
2023
Q4
$837K Buy
11,721
+324
+3% +$22.6K ﹤0.01% 2322
2023
Q3
$791K Buy
11,397
+1,209
+12% +$91.4K ﹤0.01% 2200
2023
Q2
$825K Buy
+10,188
New +$833K 0.03% 490

Other funds holding HOLX

GTS Securities's HOLX Position: Q2 2026 in Review

GTS Securities sold out of Hologic (HOLX) in Q2 2026, closing a stake of 12,908 shares — an estimated $976K sold.

GTS Securities first reported a position in HOLX in Q2 2023 and held it in 8 quarters. The position peaked at $976K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • GTS Securities reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 12,908 Hologic shares in Q2 2026, an estimated $976K.
  • GTS Securities first reported a position in Hologic in Q2 2023 and held it in 8 quarters.
  • GTS Securities's Hologic position peaked at $976K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.